Beijing Strong Biotechnologies,Inc. (SHE:300406)
China flag China · Delayed Price · Currency is CNY
13.26
+0.10 (0.76%)
Feb 4, 2026, 3:04 PM CST

SHE:300406 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Jan '22 Dec '20
Cash & Equivalents
743.821,043724.04340.72382.52577.19
Short-Term Investments
-88.4152.2325.3310.0120
Trading Asset Securities
-----5.15
Cash & Short-Term Investments
743.821,131876.24666.05392.53602.33
Cash Growth
-25.21%29.08%31.56%69.68%-34.83%166.91%
Accounts Receivable
1,0411,1651,1981,039948.99770.28
Other Receivables
24.1614.477.984.84103.7681.29
Receivables
1,0651,1791,2061,1241,053851.56
Inventory
215.29220.68229.74219.65252.01247.44
Other Current Assets
405.3550.2722.556.9343.6571
Total Current Assets
2,4302,5812,3342,0671,7411,772
Property, Plant & Equipment
552.01581.77555.24438.93366.19323.56
Long-Term Investments
57.92597.61472.73300.74397.7775
Goodwill
1,6731,6731,6731,6731,6731,673
Other Intangible Assets
51.3457.0860.4965.8373.8471.89
Long-Term Accounts Receivable
4.216.1126.314.8233.1220.88
Long-Term Deferred Tax Assets
50.4948.3745.8537.7331.3320.35
Long-Term Deferred Charges
1.551.922.853.323.333.63
Other Long-Term Assets
475.1528.565.4812.450.663.47
Total Assets
5,2955,5755,1764,6134,3203,964
Accounts Payable
55.269.2981.7137.6547.1442.29
Accrued Expenses
41.282.82108.2199.7107.3567.65
Short-Term Debt
0.080.11-81.04163.460.12
Current Portion of Long-Term Debt
5.5337.912.831.74192.9938
Current Portion of Leases
-1.461.132.020.73-
Current Income Taxes Payable
39.133.4823.1420.5326.1614.58
Current Unearned Revenue
17.9620.2718.9520.5719.4320.88
Other Current Liabilities
49.2632.7961.1334.6950.3559.12
Total Current Liabilities
208.32278.13297.12297.94607.6242.62
Long-Term Debt
1,0561,1241,1271,017766.4262
Long-Term Leases
4.345.254.911.040.91-
Long-Term Unearned Revenue
25.328.1316.9718.6520.4522.93
Long-Term Deferred Tax Liabilities
6.047.138.459.8210.9812.65
Total Liabilities
1,3001,4421,4541,3441,406540.2
Common Stock
586.31588.33588.45588.84588.98589
Additional Paid-In Capital
347.4382.47399.95392.12487.691,158
Retained Earnings
2,9473,0842,6682,2031,8731,526
Treasury Stock
-58.08-93.63-109.59-93.07-74.8-75
Comprehensive Income & Other
177.35177.52177.3179.98-0.54-0.34
Total Common Equity
4,0004,1383,7253,2712,8743,198
Minority Interest
-5.14-5.57-3.04-2.4439225.95
Shareholders' Equity
3,9954,1333,7223,2692,9133,423
Total Liabilities & Equity
5,2955,5755,1764,6134,3203,964
Total Debt
1,0661,1681,1361,1021,124300.12
Net Cash (Debt)
-321.94-37.2-259.39-436.45-731.96302.22
Net Cash Growth
-----113.33%
Net Cash Per Share
-0.54-0.06-0.44-0.71-1.250.55
Filing Date Shares Outstanding
584.78537.79559.57568.93588.98589
Total Common Shares Outstanding
584.78537.79559.57568.93588.98589
Working Capital
2,2222,3032,0371,7691,1331,530
Book Value Per Share
6.847.706.665.754.885.43
Tangible Book Value
2,2762,4091,9921,5331,1281,453
Tangible Book Value Per Share
3.894.483.562.691.922.47
Buildings
-518.07288.33288.33280.47263.14
Machinery
-297.51262.57249.98244.43207.49
Construction In Progress
--211.0374.820.086.2
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.